SCHEMBL6214532

SCHEMBL6214532

Cc1ccc(-n2c(N(C)C(=O)OCc3ccccc3)nc3ccccc3c2=O)c(C)c1

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.55
SMN1; SMN2 Q16637 2/20 0.52
KDM4E B2RXH2 2/20 0.52
MAPT P10636 1/20 0.52
TDO2 P48775 1/20 0.44
IDO2 Q6ZQW0 1/20 0.44
HTR7 P34969 3/20 0.42
PDE10A Q9Y233 3/20 0.41
LMNA P02545 5/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41
GAA P10253 2/20 0.39
ALOX15 P16050 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL449747 0.78 HTR7 (0.55) ALDH1A1SMN1; SMN2KDM4EMAPTTDO2
SCHEMBL1551501 0.73 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2KDM4EMAPTTDO2
SCHEMBL4582219 0.71 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2KDM4EMAPTTDO2
SCHEMBL1554549 0.71 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2KDM4EMAPTTDO2
SCHEMBL1553141 0.70 ALDH1A1 (0.63) ALDH1A1SMN1; SMN2KDM4EMAPTTDO2
SCHEMBL449750 0.70 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2KDM4EMAPTTDO2
SCHEMBL22736780 0.69 ALDH1A1 (0.72) ALDH1A1SMN1; SMN2KDM4EMAPTTDO2
SCHEMBL447864 0.69 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2KDM4EMAPTTDO2
SCHEMBL451427 0.69 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2KDM4EMAPTTDO2
SCHEMBL450438 0.69 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2KDM4EMAPTTDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1521746-A1 QUINAZOLINONE MODULATORS OF NUCLEAR RECEPTORS X-Ceptor Therapeutics, Inc. (US) 2005-04-13 EP disclosed
WO-2003076418-A1 QUINAZOLINONE MODULATORS OF NUCLEAR RECEPTORS X-CEPTOR THERAPEUTICS, INC. (US) 2003-09-18 WO disclosed